The delivery of safe and effective radical cure for Plasmodium vivax is one of the greatest
challenges for achieving malaria elimination from the Asia–Pacific by 2030. During the annual …

Malaria and the Spleen In this report, patients living in a malaria-endemic area underwent
trauma-related splenectomy. In these asymptomatic patients who were naturally infected with …

The rapid and aggressive spread of artemisinin-resistant Plasmodium falciparum carrying
the C580Y mutation in the kelch13 gene is a growing threat to malaria elimination in …

K13 gene mutations are a primary marker of artemisinin resistance in Plasmodium falciparum
malaria that threatens the long-term clinical utility of artemisinin-based combination …

There is an urgent need for new drugs to treat malaria, with broad therapeutic potential and
novel modes of action, to widen the scope of treatment and to overcome emerging drug …

The goal for developing new antimalarial drugs is to find a molecule that can target multiple
stages of the parasite’s life cycle, thus impacting prevention, treatment, and transmission of …

The widespread distribution and relapsing nature of Plasmodium vivax infection present
major challenges for the elimination of malaria. To characterize the genetic diversity of this …

A major obstacle to malaria elimination is the great capacity of the parasite and vector
populations to evolve in response to malaria control interventions. The widespread use of …

Importance Latent hepaticPlasmodium vivaxhypnozoites provoke repeated clinical attacks
called relapses. Only primaquine phosphate kills hypnozoites, and its therapeutic activity may …

Determining the diversity of PfEMP1 sequences expressed by Plasmodium falciparum-infected
erythrocytes isolated from placentas is important for attempts to develop a pregnancy-…